Interferon pathway in childhood lupus
Part of Immune system & allergy clinical trials.
This study looks at how a part of the immune system called the interferon pathway works in children and teenagers with lupus, especially those with kidney problems. The goal is to better understand the disease and find possible new treatment targets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with lupus before turning 18 years old
- Have signs of kidney disease from lupus (like in lab tests or a kidney biopsy) before age 18
- Willing to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test results in children and teenagers with lupus to see if they relate to how active the disease is or if it has caused long-term damage. It may help doctors better understand the disease.
This Phase 2 study tests how well the medicine mycophenolate mofetil (MMF) works for children and teens with lupus nephritis that is “proliferative” (a specific biopsy type). You may qualify if your kidney biopsy and current treatment match the study’s targets and you can follow frequent visits and testing.
This study tests anifrolumab, a new injection medicine that may help control systemic lupus erythematosus (SLE) in children and teens. Researchers will measure how the body processes the medicine and whether it helps reduce lupus activity while monitoring for side effects.
This study tests whether an intravenous medicine called anifrolumab can safely improve active systemic lupus (SLE) in children. If you qualify, you may receive the study treatment and be closely monitored for safety and lupus symptoms.
This study looks at how a treatment called CD3xCD19 BiTE affects the immune system of children with lupus that hasn't gotten better with standard medicines. It uses leftover blood samples to learn more about why some children don't respond to usual treatments.
This study looks at early heart function problems in children with lupus to find those at risk for severe disease. It may help doctors identify and treat severe lupus sooner.
Hear when a new Systemic Lupus Erythematosus of Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.